Novus to Work with New Antibody Search Engine


Novus is working with a new antibody search engine called CiteAb to ensure antibodies are easy to find and that researchers can quickly see where they have been cited in the past.

The search engine has been developed by a team based in Bath in the UK, and has been both supported and rigorously tested by the University of Bath.

Dr Andrew Chalmers is behind CiteAb. He said: “Citations are the best guide to whether an antibody is likely to work in your laboratory, they are independent and easily verifiable. We’re aiming to make CiteAb as comprehensive as possible and are delighted to be able to include Novus antibodies.”

Novus provides CiteAb with data for all of its primary antibodies. CiteAb is asking users of our antibodies to submit their publications to the site - increasing the profile of your work and helping others to find the right antibody. For more information visit

About Novus Biologicals 

Novus Biologicals is a biotechnology company whose mission is to accelerate scientific discovery by developing and marketing unique products in the forefront of science.  Novus Biologicals provides primary antibodies, secondary antibodies, conjugated antibodies, proteins, peptides, isotype and loading controls, RNAi, lysates, stem cell lines and antibody labeling kits to the bioscience community.  All of Novus' products are 100% guaranteed to work in the species and applications listed on the datasheet.  By serving niche and emerging markets, Novus Biologicals has formed and will continue to form ongoing partnerships with leading researchers.

About CiteAb 

CiteAb lists over 800,000 antibodies from 50 companies, along with the publications that cite them. CiteAb is the largest independent citation-ranked antibody search engine, and is regularly updated with new antibodies and citations.


Corey Collins, Marketing Assistant

Novus Biologicals, LLC



Release Date: 
Tuesday, February 26, 2013 - 07:00